UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: Anafranil-12mgml-Solution-SE-IS-MPD

Generated Narrative: MedicinalProductDefinition Anafranil-12mgml-Solution-SE-IS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100013348-00008757, http://ema.europa.eu/fhir/eurdId/811

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Solution for injection

indication:

Egentlig depression med melankoli. Djupa eller långvariga egentliga depressioner utan melankoli. Paniksyndrom med eller utan agorafobi. Agorafobi. Tvångstillstånd. Associerade symtom vid narkolepsi (speciellt kataplexi, sömnparalys och hypnagoga hallucinationer). Idiopatiskt smärtsyndrom med depressiva symtom.

legalStatusOfSupply: Medicinal product subject to medical prescription

classification: N06AA04

name

productName: Anafranil® 12,5 mg/ml Injektionsvätska, lösning

part

part: Anafranil®

type: Invented name part

part

part: 12.5 mg/ml

type: Strength part

part

part: Injektionsvätska, lösning

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish